Efeito do uso combinado de ácidos graxos poliinsaturados ômega 3 e estatinas sobre biomarcadores do estresse oxidativo em mulheres com dislipidemia / Effect of omega 3 polyunsaturated fatty acids suplementation combined with statins on oxidative stress measured in dyslipidemic women

AUTOR(ES)

Mariana de Magalhães Carrapeiro

DATA DE PUBLICAÇÃO

2010

RESUMO

Food and supplements that contain n-3 fatty acids, such as eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids, have been commercialized using functional claim to reduce triacylglycerol (TG) concentration and, hence, reduce the risk of cardiovascular diseases. However, as these fatty acids are highly unsaturated, the chronic consumption in high doses could raise the susceptibility of the organism to oxidative stress. Oxidative processes imbalance can be a problem in dyslipidemic individuals, once this population usually controls the high concentration of low density lipoproteins (LDL) with drugs such as statins, and oxidation of LDL is one of the most important factors to the atherosclerosis development. Since functional foods and nutraceutical supplements are supposed to contribute to the therapeutic prescription, dyslipidemic individual under statins treatment could be the target to products containing n-3 fatty acids. Thus, the objective of this study was to evaluate the effect of a supplementation containing EPA and DHA on some biomarkers of oxidative stress in women with dyslipidemia controlled by statins. A randomized double-blind placebo-controlled crossover study was carried out with 45 women who were distributed into 4 groups that received the following supplementation: corn/soy oil capsules, no statin (Placebo); corn/soy oil capsules, with statin (Statin); fish oil capsules, no statin (Omega 3); fish oil capsules, with statin (Combined). The individuals were instructed to consume 4 capsules (2.3 g of EPA and DHA) every day during 42 days. Blood samples were collected before and after the supplementation to evaluate serum glucose and lipoprotein concentrations, plasma fatty acid profile and biomarkers of oxidative stress. N-3 PUFA supplementation (2.3 g/day) was effective in reducing serum LDL and TG concentrations only when combined with statins, confirming the combined use of these compounds for improvement of lipoprotein profile. On the other hand, this supplementation seemed to induce an increase of the oxidative stress, evidenced by the higher malondialdehyde plasma concentrations, probably due to the reduction in catalase expression promoted by n-3 PUFA.

ASSUNTO(S)

humanos epa dha doenças cardiovasculares oxidative stress estresse oxidativo Ômega 3 dha human cardiovascular diseases epa omega 3

Documentos Relacionados

• Avaliação do estresse oxidativo em humanos e em animais suplementados com ácidos graxos polinsaturados omega-3
• Omega-3 and omega-6 fatty acids, dimethylsulfoxide and ternatin on hepatic regeneration and oxidative stress in rats
• Ácidos graxos poliinsaturados ômega-3 e ômega-6: importância e ocorrência em alimentos
• Eggs enrichment: utilization of fish oils and marine algae as sources of omega-3 polyunsaturated fatty acids in hensdiet.
• "Omega-3 polyunsaturated fatty acids modulated by the diet in laying hens eggs and tissues. I. Oxidation stability"